Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$4,309,228
-$1,074,077 QoQ
Shares Held
11,900
-22.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#911
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTACT INVESTMENT MANAGEMENT INC. holds $106,940,186 across 8 Drug Manufacturers - General names. AMGN ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
202,100 | $25,969,850 | |
| 2 | ABBV |
AbbVie Inc.
|
95,230 | $23,963,677 | |
| 3 | JNJ |
Johnson & Johnson
|
64,629 | $16,413,827 | |
| 4 | PFE |
Pfizer Inc
|
679,300 | $16,357,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
89,900 | $11,357,966 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
148,700 | $8,568,094 | |
| 7 | AMGN |
Amgen Inc
This page
|
11,900 | $4,309,228 | |
| 8 | LLY |
ELI LILLY & Co
|
0 | $0 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,309,228 | 11,900 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $5,383,305 | 15,300 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $5,007,843 | 15,300 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $6,321,280 | 22,400 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $7,147,776 | 25,600 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,340,420 | 36,400 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $9,669,744 | 37,100 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $8,313,018 | 25,800 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $7,904,985 | 25,300 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $12,510,080 | 44,000 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $5,155,558 | 17,900 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $4,810,804 | 17,900 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,729,026 | 21,300 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $8,026,100 | 33,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,323,720 | 35,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,716,920 | 29,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,250,340 | 29,800 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $9,527,708 | 39,400 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $14,713,038 | 65,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,059,980 | 33,200 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,092,500 | 33,200 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $8,260,492 | 33,200 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,828,928 | 38,400 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $9,759,744 | 38,400 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $11,250,522 | 47,700 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $10,298,684 | 50,800 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||